Lynryl-PM2 (10x10 T)
Description
Composition
Glimepiride 2 mg + Metformin Hydrochloride (SR) 500mg, & Pioglitazone Hydrochloride 15 mg Bilayered Tab
Lynryl-PM2 Tablets are a combination of Glimepiride, Pioglitazone, and Metformin (Sustained Release), formulated to provide comprehensive blood sugar control in adults with Type 2 Diabetes Mellitus. This triple-action therapy helps improve insulin sensitivity, stimulates insulin release, and reduces glucose production by the liver for effective long-term glycemic management.
Key Features
- Triple-action antidiabetic formulation.
- Contains Glimepiride, Pioglitazone & Metformin (SR).
- Helps maintain stable blood glucose levels throughout the day.
- Sustained-release formulation for prolonged therapeutic effect.
- Manufactured under stringent pharmaceutical quality standards.







